Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis
Meta-analysisHumans
- Design
- Meta-analysis
- Subjects
- 6 studies with 199 patients in the systematic review; 3 studies pooled
- Dose used in the study
- Not stated in the abstract
- Duration
- Searched to August 2023
- What was measured
- Intraocular pressure in glaucoma or ocular hypertension
What the authors reported
A significant reduction in intraocular pressure with palmitoylethanolamide across the pooled studies. The systematic review covered six studies (199 patients), of which three were pooled for the meta-analysis.
Limits of this study
Only three small studies were pooled, and the abstract gives no effect size or heterogeneity. The included trials are the Gagliano, Strobbe, Costagliola and Pescosolido studies already on this site, so this review adds no new patients. The Messina authors have long-standing links with Epitech.
Source
PubMed 38269580 · doi:10.1080/14786419.2024.2306916
Entry checked against the abstract on PubMed on 2026-10-19. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.